Medgenics ($MDGN) has begun a Phase IIa trial of its Epodure Biopump, delivering sustained-release EPO (erythropoietin) in dialysis patients with end-stage renal ...
> Sanovas has received a patent for its nested balloon catheter for localized drug delivery, part of its Vas Zeppelin Smart Catheter technology portfolio. Article ...
Medgenics, Inc. announces that the first new patients have now successfully commenced their treatment using biopumps producing middle dose levels of EPO in the Company’s ongoing Phase I/II clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback